Your A-Z of episodes

Peruse previous podcasts and tune into the people and topics that spark your interest. Each episode offers a brief synopsis to help you select the conversation that best fits your schedule. With most episodes lasting around 40 minutes you can scan the sector and listen to leaders while you commute, exercise or grocery shop. Select your shot of infotainment.

  • Episode 79

    The BioPharmGuy

    Adam Wilson

    / Biopharmguy

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adam Wilson, President – BioPharmGuy. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adam, covering: The humble start-up story and journey of the biopharmguy. The pivot that took the website from

  • Episode 78

    Chronicles of Swiss Biotech day

    Chronicles of Swiss Biotech day

    / Switzerland 2022

    Event season is truly well on its way and where better to start than Swiss Biotech Day, the leading biotechnology conference in Switzerland. Renowned for its innovative biotech start-ups and big pharma companies all in attendance, it was a great chance to meet experts from the life science industry from across Europe. Which is why

  • Episode 77

    From CDMO builder to CDMO creator

    Terry Novak

    / Salubrent Pharma Solutions

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Terry Novak, President & Chief Executive Officer at Salubrent Pharma Solutions. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Terry, covering: What he has learnt from 40 years in the pharma,

  • Episode 76

    Built in Boston, now rebuilding businesses

    Michael Kallelis

    / Mikart LLC

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michael Kallelis, Chief Executive Officer at Mikart. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Mike, covering: Growing up, studying and forging a career in Boston during the volatile biotech boom

  • Episode 75

    In the trenches of pharma manufacturing

    Ray Kaczmarek

    / Genezen

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ray Kaczmarek, Chief Executive Officer at Genezen. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ray, covering: Translating military life lessons into key business leadership – taking care of your people,

  • Episode 74

    From Sweden with Science

    Hans J Johansson

    / Purolite

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Hans J Johansson, Global Applications Director at Purolite. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Hans, covering: A career spent developing ideas and creating products that produce new applications for customers

  • Episode 73

    The niche, niche CDMO with enviable patient reach

    Jim Hall

    / Lifecore Biomedical

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jim Hall, President at Lifecore Biomedical Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jim, covering:  What a period working on the sponsor/buyer side taught him about getting best out of

  • Episode 72

    Diaries of DCAT

    Diaries of DCAT

    / NYC 2022

    Last week marked the return of DCAT in New York City. A prestigious event that’s open to companies engaged in the Biotech and Pharmaceutical manufacturing space… With the massive return this year of events. Your host, Raman Sehgal, decided to shake things up this year and do things differently, taking your favourite life science podcast

  • Episode 71

    Finland’s Viral Vector Manufacturer of Happinesses

    Magnus Gustafsson

    / Biovian

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Magnus Gustafsson, formerly at the time of recording Head of Global Business Development now Chief Business Officer at Biovian. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Magnus, covering: The advantages

  • Episode 70

    From corporate rebel to CDMO entrepreneur

    Hanns-Christian Mahler

    / ten23 health

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Hanns-Christian Mahler CEO at ten23 health. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Hanns, covering: Transitioning from the structure and scale of Merck, Roche and Lonza into an entrepreneurial start-up

  • Load more